REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/26/2025
Back to search
Official data from USPTO
A ATHERSYS INC.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
56
Latest update
09/27/2025
Trademark type
Combined
Nice classes
1, 42
Filing date
04/06/2004
Registration date
09/26/2006
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/01/2016
Last transaction
09/27/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2004-02-00
First use in commerce
2004-02-00
Drawing code
3
Owner type
03
Owner location
Cleveland, OH
Examiner
CHENG, CHI TANG P
Law office
M50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
ABT HOLDING COMPANY
Athersys, Inc.
Representatives
Rita E. Kline Renner, Otto, Boisselle & Sklar, LLP
Technical classification
Nice Classes
Class 1Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Cells for scientificlaboratory and medical researchthe cells having genetic characteristics that render the cells useful in the development of therapeutic and diagnostic compoundsthat render the cells useful in the discovery of medically relevant genesthat render the cells useful in the development of data for drug modeling; and artificial genetic material intended to mimic chromosomes for scientificlaboratory and medical researchthe artificial genetic material being insertable into cells and being reproduced upon cell division
Class 42
Clinical and scientific research directed to developing cells having genetic characteristics that are useful in the development of therapeutic and diagnostic compounds; clinical and scientific research directed to the development of compounds for therapy and diagnosis; clinical and scientific research directed to the discovery of medically relevant genes; clinical and scientific research directed to the development of cells for use as a therapeutic agent; clinical and scientific research directed to the development of data for drug modeling; and providing a database of drug modeling data to others
Publications
History of USPTO decisions and trademark events.
56 publications found
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/01/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/01/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/01/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/01/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/01/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/07/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/07/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/07/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/07/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/07/2020
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/01/2016
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
12/01/2016
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/01/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/01/2016
E89R
TEAS SECTION 8 & 9 RECEIVED
09/20/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/20/2016
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/26/2015
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
06/04/2015
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
03/11/2015
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
12/02/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/24/2014
ES7R
TEAS SECTION 7 REQUEST RECEIVED
11/12/2014
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/27/2012
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/27/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/26/2012
E815
TEAS SECTION 8 & 15 RECEIVED
09/17/2012
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/27/2011
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06/08/2011
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/02/2011
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/02/2011
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
08/08/2007
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
07/04/2007
R.PR
REGISTERED-PRINCIPAL REGISTER
09/26/2006
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
08/08/2006
ALIE
ASSIGNED TO LIE
08/04/2006
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/27/2006
DOCK
ASSIGNED TO EXAMINER
07/13/2006
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/31/2006
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/18/2006
IUAF
USE AMENDMENT FILED
01/23/2006
PAPER RECEIVED
01/23/2006
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
07/26/2005
PUBO
PUBLISHED FOR OPPOSITION
05/03/2005
NPUB
NOTICE OF PUBLICATION
04/13/2005
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/10/2005
ALIE
ASSIGNED TO LIE
02/04/2005
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/28/2005
ACEC
AMENDMENT FROM APPLICANT ENTERED
01/10/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/22/2004
PAPER RECEIVED
12/22/2004
PAPER RECEIVED
12/21/2004
CPEA
EXAMINER'S AMENDMENT AND/OR PRIORITY ACTION MAILED
10/28/2004
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
10/27/2004
DOCK
ASSIGNED TO EXAMINER
10/27/2004
NWAP
NEW APPLICATION ENTERED
04/23/2004
Continuous trademark protection
Get notified about every new filing that threatens A ATHERSYS INC. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.